HEADER FLAVOPROTEIN, OXIDOREDUCTASE 24-SEP-10 3OZ2 TITLE CRYSTAL STRUCTURE OF A GERANYLGERANYL BACTERIOCHLOROPHYLL REDUCTASE- TITLE 2 LIKE (TA0516) FROM THERMOPLASMA ACIDOPHILUM AT 1.60 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIGERANYLGERANYLGLYCEROPHOSPHOLIPID REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DGGGPL REDUCTASE, 2,3-DI-O-GERANYLGERANYLGLYCERYL PHOSPHATE COMPND 5 REDUCTASE, GERANYLGERANYL REDUCTASE, GGR; COMPND 6 EC: 1.3.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOPLASMA ACIDOPHILUM; SOURCE 3 ORGANISM_COMMON: ARCHAEA; SOURCE 4 ORGANISM_TAXID: 2303; SOURCE 5 GENE: TA0516; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, FLAVOPROTEIN, KEYWDS 3 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3OZ2 1 REMARK SEQADV LINK REVDAT 3 20-JUL-11 3OZ2 1 KEYWDS REVDAT 2 23-MAR-11 3OZ2 1 KEYWDS REVDAT 1 27-OCT-10 3OZ2 0 SPRSDE 27-OCT-10 3OZ2 3CGV JRNL AUTH Q.XU,T.EGUCHI,I.I.MATHEWS,C.L.RIFE,H.J.CHIU,C.L.FARR, JRNL AUTH 2 J.FEUERHELM,L.JAROSZEWSKI,H.E.KLOCK,M.W.KNUTH,M.D.MILLER, JRNL AUTH 3 D.WEEKES,M.A.ELSLIGER,A.M.DEACON,A.GODZIK,S.A.LESLEY, JRNL AUTH 4 I.A.WILSON JRNL TITL INSIGHTS INTO SUBSTRATE SPECIFICITY OF GERANYLGERANYL JRNL TITL 2 REDUCTASES REVEALED BY THE STRUCTURE OF JRNL TITL 3 DIGERANYLGERANYLGLYCEROPHOSPHOLIPID REDUCTASE, AN ESSENTIAL JRNL TITL 4 ENZYME IN THE BIOSYNTHESIS OF ARCHAEAL MEMBRANE LIPIDS. JRNL REF J.MOL.BIOL. V. 404 403 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20869368 JRNL DOI 10.1016/J.JMB.2010.09.032 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 55071 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.171 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2794 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3771 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE SET COUNT : 201 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3004 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 157 REMARK 3 SOLVENT ATOMS : 332 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.57000 REMARK 3 B22 (A**2) : 1.08000 REMARK 3 B33 (A**2) : -0.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.079 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.074 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.046 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.679 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.968 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3467 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2432 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4717 ; 1.608 ; 2.014 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5996 ; 0.911 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 471 ; 6.320 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 135 ;36.406 ;24.519 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 620 ;12.230 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;16.988 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 525 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3826 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 657 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2096 ; 1.497 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 861 ; 0.422 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3394 ; 2.518 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1371 ; 4.121 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1288 ; 6.476 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 396 REMARK 3 RESIDUE RANGE : A 501 A 501 REMARK 3 RESIDUE RANGE : A 502 A 502 REMARK 3 ORIGIN FOR THE GROUP (A): 13.7612 50.0025 25.9353 REMARK 3 T TENSOR REMARK 3 T11: 0.0365 T22: 0.0253 REMARK 3 T33: 0.0170 T12: 0.0052 REMARK 3 T13: -0.0031 T23: 0.0049 REMARK 3 L TENSOR REMARK 3 L11: 0.7487 L22: 0.5438 REMARK 3 L33: 0.8513 L12: -0.1416 REMARK 3 L13: 0.2747 L23: -0.3801 REMARK 3 S TENSOR REMARK 3 S11: -0.0504 S12: -0.1026 S13: 0.0454 REMARK 3 S21: 0.1346 S22: 0.0207 S23: -0.0113 REMARK 3 S31: -0.0587 S32: -0.0632 S33: 0.0298 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 4. WATERS WERE EXCLUDED FROM AUTOMATIC TLS ASSIGNMENT. REMARK 3 5. FAD IS MODELED BASED ON DENSITY AND FUNCTION. 6. A BACTERIAL REMARK 3 LIPID FOUND IN THE ACTIVE SITE WAS TENTATIVELY ASSIGNED AS A REMARK 3 PHOSPHATIDYLGYLCEROL (OZ2) BASED ON DENSITY AND FUNCTION. THE REMARK 3 DENSITY FOR THE HEAD GROUP AND LIPID TAILS ARE POORLY DEFINED. REMARK 3 7. ETHYLENE GLYCOL (EDO) AND GLYCEROL (GOL) WERE MODELED BASED REMARK 3 ON CRYSTALLIZATION/CYRO CONDITIONS. REMARK 4 REMARK 4 3OZ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061751. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97920,0.97862 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55071 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 45.257 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15.00% GLYCEROL, 8.50% ISO-PROPANOL, REMARK 280 17.00% PEG-4000, 0.1M HEPES PH 7.5, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.79500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.92500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.33500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.92500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.79500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.33500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 ARG A 62 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 GLU A 88 CG CD OE1 OE2 REMARK 470 LYS A 89 CG CD CE NZ REMARK 470 HIS A 232 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 234 CZ NH1 NH2 REMARK 470 LYS A 348 CD CE NZ REMARK 470 GLU A 387 CG CD OE1 OE2 REMARK 470 VAL A 388 CG1 CG2 REMARK 470 VAL A 389 CG1 CG2 REMARK 470 GLU A 391 CG CD OE1 OE2 REMARK 470 GLU A 393 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 101 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 80 -135.05 -69.16 REMARK 500 TRP A 230 -61.80 -105.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OZ2 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 509 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 510 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 511 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 512 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 513 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 514 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 515 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 382454 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE. DBREF 3OZ2 A 1 396 UNP Q9HKS9 GGR_THEAC 1 396 SEQADV 3OZ2 GLY A 0 UNP Q9HKS9 EXPRESSION TAG SEQRES 1 A 397 GLY MSE GLU THR TYR ASP VAL LEU VAL VAL GLY GLY GLY SEQRES 2 A 397 PRO GLY GLY SER THR ALA ALA ARG TYR ALA ALA LYS TYR SEQRES 3 A 397 GLY LEU LYS THR LEU MSE ILE GLU LYS ARG PRO GLU ILE SEQRES 4 A 397 GLY SER PRO VAL ARG CYS GLY GLU GLY LEU SER LYS GLY SEQRES 5 A 397 ILE LEU ASN GLU ALA ASP ILE LYS ALA ASP ARG SER PHE SEQRES 6 A 397 ILE ALA ASN GLU VAL LYS GLY ALA ARG ILE TYR GLY PRO SEQRES 7 A 397 SER GLU LYS ARG PRO ILE ILE LEU GLN SER GLU LYS ALA SEQRES 8 A 397 GLY ASN GLU VAL GLY TYR VAL LEU GLU ARG ASP LYS PHE SEQRES 9 A 397 ASP LYS HIS LEU ALA ALA LEU ALA ALA LYS ALA GLY ALA SEQRES 10 A 397 ASP VAL TRP VAL LYS SER PRO ALA LEU GLY VAL ILE LYS SEQRES 11 A 397 GLU ASN GLY LYS VAL ALA GLY ALA LYS ILE ARG HIS ASN SEQRES 12 A 397 ASN GLU ILE VAL ASP VAL ARG ALA LYS MSE VAL ILE ALA SEQRES 13 A 397 ALA ASP GLY PHE GLU SER GLU PHE GLY ARG TRP ALA GLY SEQRES 14 A 397 LEU LYS SER VAL ILE LEU ALA ARG ASN ASP ILE ILE SER SEQRES 15 A 397 ALA LEU GLN TYR ARG MSE ILE ASN VAL ASP VAL ASP PRO SEQRES 16 A 397 ASP TYR THR ASP PHE TYR LEU GLY SER ILE ALA PRO ALA SEQRES 17 A 397 GLY TYR ILE TRP VAL PHE PRO LYS GLY GLU GLY MSE ALA SEQRES 18 A 397 ASN VAL GLY ILE GLY SER SER ILE ASN TRP ILE HIS ASN SEQRES 19 A 397 ARG PHE GLU LEU LYS ASN TYR LEU ASP ARG PHE ILE GLU SEQRES 20 A 397 ASN HIS PRO GLY LEU LYS LYS GLY GLN ASP ILE GLN LEU SEQRES 21 A 397 VAL THR GLY GLY VAL SER VAL SER LYS VAL LYS MSE PRO SEQRES 22 A 397 ILE THR MSE PRO GLY LEU MSE LEU VAL GLY ASP ALA ALA SEQRES 23 A 397 ARG LEU ILE ASP PRO ILE THR GLY GLY GLY ILE ALA ASN SEQRES 24 A 397 ALA ILE VAL SER GLY MSE TYR ALA ALA GLN VAL THR LYS SEQRES 25 A 397 GLU ALA ILE GLU SER ASN ASP TYR SER PRO GLN MSE MSE SEQRES 26 A 397 GLN LYS TYR GLU LYS LEU ILE LYS GLU ARG PHE GLU ARG SEQRES 27 A 397 LYS HIS LEU ARG ASN TRP VAL ALA LYS GLU LYS LEU ALA SEQRES 28 A 397 MSE LEU SER ASP ASP THR LEU ASP LYS LEU VAL ASP ILE SEQRES 29 A 397 VAL SER GLU GLN VAL LEU THR THR ILE SER VAL GLU ALA SEQRES 30 A 397 ILE LEU LYS ALA ILE ALA GLU LYS TYR PRO GLU VAL VAL SEQRES 31 A 397 LYS GLU LEU GLU ASP LEU ILE MODRES 3OZ2 MSE A 1 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 31 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 152 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 187 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 219 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 271 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 275 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 279 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 304 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 323 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 324 MET SELENOMETHIONINE MODRES 3OZ2 MSE A 351 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 31 8 HET MSE A 152 8 HET MSE A 187 13 HET MSE A 219 13 HET MSE A 271 8 HET MSE A 275 13 HET MSE A 279 8 HET MSE A 304 13 HET MSE A 323 8 HET MSE A 324 8 HET MSE A 351 13 HET FAD A 501 53 HET OZ2 A 502 48 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4 HET EDO A 507 4 HET EDO A 508 4 HET EDO A 509 4 HET EDO A 510 4 HET EDO A 511 4 HET EDO A 512 4 HET EDO A 513 4 HET GOL A 514 6 HET GOL A 515 6 HETNAM MSE SELENOMETHIONINE HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM OZ2 (2R)-3-{[(R)-{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY) HETNAM 2 OZ2 PHOSPHORYL]OXY}-2-[(6Z)-TRIDEC-6-ENOYLOXY]PROPYL (9Z)- HETNAM 3 OZ2 OCTADEC-9-ENOATE HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 OZ2 C37 H69 O10 P FORMUL 4 EDO 11(C2 H6 O2) FORMUL 15 GOL 2(C3 H8 O3) FORMUL 17 HOH *332(H2 O) HELIX 1 1 GLY A 12 TYR A 25 1 14 HELIX 2 2 LYS A 50 ALA A 56 1 7 HELIX 3 3 GLU A 99 GLY A 115 1 17 HELIX 4 4 SER A 161 GLY A 168 1 8 HELIX 5 5 LEU A 169 ILE A 173 5 5 HELIX 6 6 ALA A 175 ASN A 177 5 3 HELIX 7 7 ASN A 233 ASN A 247 1 15 HELIX 8 8 HIS A 248 LYS A 253 1 6 HELIX 9 9 GLY A 282 ARG A 286 5 5 HELIX 10 10 GLY A 295 ASN A 317 1 23 HELIX 11 11 SER A 320 MSE A 351 1 32 HELIX 12 12 SER A 353 SER A 365 1 13 HELIX 13 13 SER A 373 TYR A 385 1 13 HELIX 14 14 PRO A 386 ILE A 396 5 11 SHEET 1 A 6 ASP A 117 TRP A 119 0 SHEET 2 A 6 THR A 29 ILE A 32 1 N THR A 29 O ASP A 117 SHEET 3 A 6 MSE A 1 VAL A 9 1 N VAL A 8 O LEU A 30 SHEET 4 A 6 GLU A 144 ALA A 155 1 O ILE A 154 N LEU A 7 SHEET 5 A 6 LYS A 133 HIS A 141 -1 N ILE A 139 O VAL A 146 SHEET 6 A 6 ALA A 124 GLU A 130 -1 N LEU A 125 O LYS A 138 SHEET 1 B 6 ASP A 117 TRP A 119 0 SHEET 2 B 6 THR A 29 ILE A 32 1 N THR A 29 O ASP A 117 SHEET 3 B 6 MSE A 1 VAL A 9 1 N VAL A 8 O LEU A 30 SHEET 4 B 6 GLU A 144 ALA A 155 1 O ILE A 154 N LEU A 7 SHEET 5 B 6 LEU A 278 LEU A 280 1 O MSE A 279 N ALA A 155 SHEET 6 B 6 THR A 274 MSE A 275 -1 N MSE A 275 O LEU A 278 SHEET 1 C 3 GLY A 47 SER A 49 0 SHEET 2 C 3 GLY A 95 LEU A 98 -1 O TYR A 96 N LEU A 48 SHEET 3 C 3 ILE A 65 VAL A 69 -1 N ASN A 67 O VAL A 97 SHEET 1 D 7 ILE A 83 GLN A 86 0 SHEET 2 D 7 GLY A 71 TYR A 75 -1 N ILE A 74 O ILE A 83 SHEET 3 D 7 TYR A 196 TYR A 200 1 O PHE A 199 N TYR A 75 SHEET 4 D 7 GLY A 208 GLY A 216 -1 O ILE A 210 N TYR A 200 SHEET 5 D 7 MSE A 219 SER A 227 -1 O ASN A 221 N PHE A 213 SHEET 6 D 7 ILE A 179 ILE A 188 -1 N TYR A 185 O VAL A 222 SHEET 7 D 7 GLN A 255 SER A 265 -1 O ILE A 257 N ARG A 186 LINK C GLY A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N GLU A 2 1555 1555 1.36 LINK C LEU A 30 N MSE A 31 1555 1555 1.33 LINK C MSE A 31 N ILE A 32 1555 1555 1.33 LINK C LYS A 151 N MSE A 152 1555 1555 1.35 LINK C MSE A 152 N VAL A 153 1555 1555 1.31 LINK C ARG A 186 N MSE A 187 1555 1555 1.32 LINK C MSE A 187 N ILE A 188 1555 1555 1.33 LINK C GLY A 218 N MSE A 219 1555 1555 1.34 LINK C MSE A 219 N ALA A 220 1555 1555 1.34 LINK C LYS A 270 N MSE A 271 1555 1555 1.33 LINK C MSE A 271 N PRO A 272 1555 1555 1.34 LINK C THR A 274 N MSE A 275 1555 1555 1.32 LINK C MSE A 275 N PRO A 276 1555 1555 1.35 LINK C LEU A 278 N MSE A 279 1555 1555 1.33 LINK C MSE A 279 N LEU A 280 1555 1555 1.33 LINK C GLY A 303 N MSE A 304 1555 1555 1.33 LINK C MSE A 304 N TYR A 305 1555 1555 1.33 LINK C GLN A 322 N MSE A 323 1555 1555 1.33 LINK C MSE A 323 N MSE A 324 1555 1555 1.32 LINK C MSE A 324 N GLN A 325 1555 1555 1.33 LINK C ALA A 350 N MSE A 351 1555 1555 1.33 LINK C MSE A 351 N LEU A 352 1555 1555 1.33 CISPEP 1 SER A 40 PRO A 41 0 -2.43 CISPEP 2 MSE A 271 PRO A 272 0 0.63 SITE 1 AC1 37 GLY A 10 GLY A 12 PRO A 13 GLY A 14 SITE 2 AC1 37 GLU A 33 LYS A 34 ARG A 35 ARG A 43 SITE 3 AC1 37 CYS A 44 GLY A 45 GLU A 46 GLY A 47 SITE 4 AC1 37 ARG A 100 PRO A 123 ALA A 124 ALA A 156 SITE 5 AC1 37 ASP A 157 GLY A 158 GLU A 162 PHE A 213 SITE 6 AC1 37 VAL A 264 GLY A 282 ASP A 283 GLY A 294 SITE 7 AC1 37 GLY A 295 ILE A 296 ALA A 299 OZ2 A 502 SITE 8 AC1 37 HOH A 517 HOH A 518 HOH A 524 HOH A 528 SITE 9 AC1 37 HOH A 622 HOH A 623 HOH A 628 HOH A 630 SITE 10 AC1 37 HOH A 687 SITE 1 AC2 18 SER A 49 TYR A 209 TRP A 211 PRO A 290 SITE 2 AC2 18 ILE A 291 THR A 292 GLY A 293 LYS A 338 SITE 3 AC2 18 LEU A 349 ILE A 372 SER A 373 VAL A 374 SITE 4 AC2 18 FAD A 501 EDO A 508 GOL A 515 HOH A 655 SITE 5 AC2 18 HOH A 805 HOH A 836 SITE 1 AC3 6 VAL A 118 TRP A 119 VAL A 120 HIS A 141 SITE 2 AC3 6 HOH A 575 HOH A 790 SITE 1 AC4 4 LYS A 138 GLU A 312 GLU A 315 HOH A 616 SITE 1 AC5 5 GLY A 132 LYS A 133 VAL A 134 MSE A 275 SITE 2 AC5 5 HOH A 585 SITE 1 AC6 3 TYR A 4 HOH A 670 HOH A 747 SITE 1 AC7 6 ASN A 177 SER A 227 LYS A 346 GLU A 347 SITE 2 AC7 6 HOH A 617 HOH A 785 SITE 1 AC8 6 ASP A 289 THR A 292 GLY A 294 ASN A 298 SITE 2 AC8 6 OZ2 A 502 EDO A 509 SITE 1 AC9 6 ASN A 298 VAL A 301 ARG A 334 LYS A 338 SITE 2 AC9 6 EDO A 508 HOH A 666 SITE 1 BC1 3 ASP A 117 TRP A 119 HOH A 635 SITE 1 BC2 4 HOH A 558 HOH A 684 HOH A 769 HOH A 788 SITE 1 BC3 5 ALA A 23 LEU A 27 HOH A 557 HOH A 633 SITE 2 BC3 5 HOH A 705 SITE 1 BC4 7 GLY A 254 LYS A 270 MSE A 271 HOH A 589 SITE 2 BC4 7 HOH A 626 HOH A 672 HOH A 765 SITE 1 BC5 8 PRO A 272 THR A 274 MSE A 275 PRO A 321 SITE 2 BC5 8 MSE A 324 GLN A 325 GLU A 328 HOH A 604 SITE 1 BC6 6 GLY A 47 LEU A 48 SER A 49 VAL A 69 SITE 2 BC6 6 THR A 197 OZ2 A 502 CRYST1 49.590 70.670 117.850 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020165 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014150 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008485 0.00000